drugset / Trial / NCT00237341
Duragesic® (Fentanyl Transdermal System) Functionality Trial in Chronic Low Back Pain
Summary
The purpose of this study is to assess physical functionality changes over a minimum of 9 weeks in patients with non-malignant chronic low back pain who are taking short-acting opioids (narcotic pain medications) for 4 or more weeks, and who start taking the long-acting opioid fentanyl in the form of a transdermal (skin) patch.
Timeline
- Start
- 2002-06
- Primary completion
- —
- Completion
- 2004-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fentanyl | Other / unclassified | 25 ug | Other |
| Subject | Fentanyl | Other / unclassified | 50 ug | Other |
| Subject | Fentanyl | Other / unclassified | 75 ug | Other |
| Subject | Fentanyl | Other / unclassified | 100 ug | Other |
Indications
No indication recorded.